About OncoLens
OncoLens is an AI-driven oncology care platform that delivers multidisciplinary team collaboration, analytics, and clinical decision support tools for cancer treatment planning. The platform integrates patient data across EMRs, genomics, and pathology systems, and automates tumor board management, accreditation reporting, and patient identification for clinical trials. Its customers include cancer centers and pharmaceutical companies across the U.S.
Company details
Funding
Total raised
$27.1M
Last stage
Series B
Investors
Founders
Anju Mathew
Serial entrepreneur and technologist; previously Head of Technology and Innovation at McKesson Medical Surgical; co-founded LumaMed; MBA from Northwestern University's Kellogg School of Management.
LinkedInLijo Simpson
Board-certified Hematologist/Oncologist and active participant in various cancer committees; co-founded OncoLens alongside Anju Mathew.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.